Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study
Abroad (travel likely)RecruitingPHASE2
Conditions
Progressive Multifocal Leukoencephalopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · (800) 411-1222
Study leads
Irene CM Cortese, M.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)